News and Analysis

Biopharma has finally begun catching up with the overall stock market, if the positive returns shown by the top three exchange traded funds (ETFs) since

Sen. Rand Paul (R-Ky.) called on President Trump to appoint a select group of bipartisan senators to a commission tasked with addressing the expiring health

More than two years after the mpox outbreak in the U.S. was declared over, a new crop of cases in California has infectious disease experts

Cybercriminals today aren’t just targeting Fortune 500s. With nearly half of all cyber breaches affecting organizations with less than 1,000 employees, small to mid-sized enterprises have now